Clinical Trials Directory

Trials / Unknown

UnknownNCT03212001

TeleHomecaRe InterVention Evaluation Study

TeleHomecaRe InterVention Evaluation (THRIVE) Study

Status
Unknown
Phase
Study type
Observational
Enrollment
5,400 (estimated)
Sponsor
University of Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to evaluate the overall impact of Telehomecare on COPD and HF patients and system level outcomes using a comparison group of patients that did not participate in the program (for up to 18 months). This evaluation study will explore costs, participants' experiences, perceptions, and patterns of use related to Telehomecare. The study will include eight Local Health Integration Networks (LHINs) across Ontario, Canada.

Detailed description

The key question to answer is how different models of Telehomecare enabled self-management impacts patient outcomes, experiences and system costs across Ontario. The evaluation study will also attempt to answer questions on who is benefitting the most from the program and the quantifiable benefits a patient would experience from participating. The intervention evaluation study will use a mixed-methods design comprising of four components (sub-studies), using both qualitative and quantitative research methods: (1) Comparative Effectiveness Study that evaluates patient-level clinical outcomes (e.g. hospitalization, ED visits) using administrative data in comparison with usual care; (2) Economic Evaluation Study that will evaluate costs associated with the program and patient level outcomes as well as cost-effectiveness of the program in comparison with 'usual care'; (3) Evaluation study of Telehomecare use that will evaluate the patterns of program use and perceived quality of life, disease management, satisfaction and caregiver strain; and (4) Adoption study that will use ethnographic fieldwork, semi-structured interviews (during and after program participation) and review of documentary sources to gain understanding of program adoption.

Conditions

Timeline

Start date
2016-07-01
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2017-07-11
Last updated
2019-04-25

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03212001. Inclusion in this directory is not an endorsement.